SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors

Acta Pharmacologica Sinica, Published online: 11 September 2020; doi:10.1038/s41401-020-00513-3SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors

http://feeds.nature.com/~r/aps/rss/current/~3/_j8iTqFxdoY/s41401-020-00513-3

Source: Acta Pharmacologica Sinica - September 10, 2020 Category: Drugs & Pharmacology Authors: Zong-jun Xia Yin-chun Ji De-qiao Sun Xia Peng Ying-lei Gao Yan-fen Fang Xing-dong Zhao Wei-bo Wang Jian Ding Mei-yu Geng Jing Ai Source Type: research

More News: Drugs & Pharmacology